158 related articles for article (PubMed ID: 29025819)
1. Time in therapeutic range: Warfarin anticoagulation for atrial fibrillation in a community-based practice.
Gateman D; Trojnar ME; Agarwal G
Can Fam Physician; 2017 Oct; 63(10):e425-e431. PubMed ID: 29025819
[TBL] [Abstract][Full Text] [Related]
2. Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management.
Bahbahani H; AlTurki A; Dawas A; Lipman ML
BMC Nephrol; 2018 Jan; 19(1):4. PubMed ID: 29310600
[TBL] [Abstract][Full Text] [Related]
3. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
[TBL] [Abstract][Full Text] [Related]
4. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
Pokorney SD; Simon DN; Thomas L; Fonarow GC; Kowey PR; Chang P; Singer DE; Ansell J; Blanco RG; Gersh B; Mahaffey KW; Hylek EM; Go AS; Piccini JP; Peterson ED;
Am Heart J; 2015 Jul; 170(1):141-8, 148.e1. PubMed ID: 26093875
[TBL] [Abstract][Full Text] [Related]
5. Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.
McAlister FA; Wiebe N; Hemmelgarn BR
BMJ Open; 2018 Jan; 8(1):e016980. PubMed ID: 29382672
[TBL] [Abstract][Full Text] [Related]
6. Quality of warfarin control in atrial fibrillation patients in South East Queensland, Australia.
Bernaitis N; Badrick T; Davey AK; Anoopkumar-Dukie S
Intern Med J; 2016 Aug; 46(8):925-31. PubMed ID: 27040159
[TBL] [Abstract][Full Text] [Related]
7. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting.
Han SY; Palmeri ST; Broderick SH; Hasselblad V; Rendall D; Stevens S; Tenaglia A; Velazquez E; Whellan D; Wagner G; Heitner JF
J Electrocardiol; 2013; 46(1):45-50. PubMed ID: 23063241
[TBL] [Abstract][Full Text] [Related]
8. Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation.
Deitelzweig S; Evans M; Hillson E; Trocio J; Bruno A; Tan W; Lingohr-Smith M; Singh P; Lin J
Curr Med Res Opin; 2016; 32(1):87-94. PubMed ID: 26451675
[TBL] [Abstract][Full Text] [Related]
9. Impact of co-morbidities and patient characteristics on international normalized ratio control over time in patients with nonvalvular atrial fibrillation.
Nelson WW; Choi JC; Vanderpoel J; Damaraju CV; Wildgoose P; Fields LE; Schein JR
Am J Cardiol; 2013 Aug; 112(4):509-12. PubMed ID: 23800552
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia.
Yimer NS; Abiye AA; Hussen SU; Tadesse TA
Clin Appl Thromb Hemost; 2021; 27():10760296211049786. PubMed ID: 34724849
[TBL] [Abstract][Full Text] [Related]
11. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
Macedo AF; Bell J; McCarron C; Conroy R; Richardson J; Scowcroft A; Sunderland T; Rotheram N
Thromb Res; 2015 Aug; 136(2):250-60. PubMed ID: 26073321
[TBL] [Abstract][Full Text] [Related]
12. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
[TBL] [Abstract][Full Text] [Related]
13. Quality of oral anticoagulation control in Chinese patients with non-valvular atrial fibrillation: a prospective controlled study.
Li Y; Yu J; Kuang Y; Wu C; Yang L; Fang Q; Pei Q; Yang G
Curr Med Res Opin; 2020 Sep; 36(9):1433-1439. PubMed ID: 32677855
[TBL] [Abstract][Full Text] [Related]
14. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.
Menzin J; Boulanger L; Hauch O; Friedman M; Marple CB; Wygant G; Hurley JS; Pezzella S; Kaatz S
Ann Pharmacother; 2005 Mar; 39(3):446-51. PubMed ID: 15701783
[TBL] [Abstract][Full Text] [Related]
15. Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.
Williams BA; Evans MA; Honushefsky AM; Berger PB
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025746
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina.
Tajer C; Ceresetto J; Bottaro FJ; Martí A; Casey M;
Clin Appl Thromb Hemost; 2017 Jul; 23(5):445-453. PubMed ID: 26739542
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.
Sridhar VS; Leung P; Seymour N; Nagge J
Can Fam Physician; 2014 Nov; 60(11):e535-40. PubMed ID: 25551135
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
